{"originalText": "，患者6月余前因“直肠癌”在我院行直肠癌DIXON手术，手术过程顺利，术后给予抗感染、营养支持并补液治疗，患者2017-02-15因“直肠癌术后吻合口瘘”行“横结肠造口术”，手术过程顺利，术后给予抗感染、营养支持、补液及对症治疗，，术后病理检查结果回示：（直肠）腺癌（中、低度分化，局部伴神经内分泌分化；部分为粘液腺癌，约占30%）， 隆起型，体积2*2*1.5CM，局部侵达深肌层，并肠壁外脂肪组织内查见癌转移 灶（1处），长径约0.7CM，双端切线及另送“近切线”、“远切线”未查见癌。 多发性增生性（锯齿状）息肉。 一站淋巴结（8个）未查见癌。，癌组织免疫组化染色示：SYN局部（+）、BRAF（-）、MSH2（+）、MSH6（+）、 MLH1（+）、PMS2（+）。病情稳定后出院.患者于2017-6-2、2017-7-2及2017-7-30来我院入住我科，排除化疗禁忌后给予奥沙利铂200MGD1+氟尿嘧啶0.75G D2-D6+亚叶酸钙0.3G D2-D6，辅以保肝、护胃、止吐等对症支持治疗，过程顺利，患者耐受可，化疗结束后出院。   出院后患者病情稳定，无发热畏寒，无恶心呕吐，无咳嗽胸闷，无腹胀腹泻以及腹痛，精神好，饮食好，睡眠好，小便正常，体重无明显改变。现患者为求进一步治疗入院，门诊以“直肠癌术后”收入院。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"end_pos": 27, "label_type": "手术", "overlap": 0, "start_pos": 17}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 67, "end_pos": 76}, {"end_pos": 85, "label_type": "手术", "overlap": 0, "start_pos": 79}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 127, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 194}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 246, "end_pos": 259}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 266}, {"end_pos": 396, "label_type": "药物", "overlap": 0, "start_pos": 392}, {"end_pos": 408, "label_type": "药物", "overlap": 0, "start_pos": 404}, {"end_pos": 424, "label_type": "药物", "overlap": 0, "start_pos": 420}, {"end_pos": 439, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"end_pos": 442, "label_type": "解剖部位", "overlap": 0, "start_pos": 441}, {"end_pos": 501, "label_type": "解剖部位", "overlap": 0, "start_pos": 500}, {"end_pos": 505, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}, {"end_pos": 507, "label_type": "解剖部位", "overlap": 0, "start_pos": 506}, {"end_pos": 511, "label_type": "解剖部位", "overlap": 0, "start_pos": 510}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 555, "end_pos": 560}]}
